(AP Photo/Julia Weeks)

Pfiz­er's Paxlovid gets March FDA ad­vi­so­ry meet­ing to dis­cuss full ap­proval

Pfiz­er’s an­tivi­ral drug for Covid-19 is look­ing to inch clos­er to full FDA ap­proval, with an agency ad­vi­so­ry com­mit­tee sched­uled for March.

The meet­ing is …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.